Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Hankil, Lee"'
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 6, Pp 967-978 (2024)
Background/Aims The corona virus disease 2019 posed a major risk for end-stage kidney disease (ESKD) cases. Our study aimed to assess changes in kidney replacement therapy (KRT) trends and healthcare access for these patients during the pandemic. Met
Externí odkaz:
https://doaj.org/article/1cc8674f6da6450e9679565b30bf337a
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 1, Pp 102-108 (2024)
Background: With the outbreak of COVID-19, school closures and quarantines following social distancing have brought significant changes to children's lifestyles. Therefore, we aimed to compare the population-adjusted incidence of febrile seizures(FS)
Externí odkaz:
https://doaj.org/article/25b7ed95303844798ffb45f617a09a22
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 4, Pp n/a-n/a (2024)
Abstract As the importance of utilizing real‐world data (RWD)/real‐world evidence (RWE) for supporting regulatory scientific decision‐making continues to grow, experiences and inputs from experts become crucial for developing a systematic and p
Externí odkaz:
https://doaj.org/article/095186cf933d40d894c20348d92e815b
Publikováno v:
Archives of Public Health, Vol 81, Iss 1, Pp 1-22 (2023)
Abstract Background People with hearing impairment have many problems with healthcare use, which is associated with health literacy. Research on health literacy is less focused on people with hearing impairments. This research aimed to explore the le
Externí odkaz:
https://doaj.org/article/692ebab8c36943afafff697716d60f47
Autor:
Seoyeon Park, Min Seo Kim, Dong Keon Yon, Seung Won Lee, Joseph L Ward, Susan A McLaughlin, Max L Mehlman, Ai Koyanagi, Lee Smith, Louis Jacob, Suneth Buddhika Agampodi, Maryam Beiranvand, Dong-Woo Choi, Sung Hwi Hong, Mehdi Hosseinzadeh, Cho-il Kim, Gyu Ri Kim, Jihee Kim, Kwanghyun Kim, Sungroul Kim, Doo Woong Lee, Hankil Lee, Sang-woong Lee, Yo Han Lee, Ali H Mokdad, Christopher J L Murray, Akinkunmi Paul Okekunle, Eun-Cheol Park, Navid Rabiee, Youn Ho Shin, Simon I Hay, Jae Il Shin
Publikováno v:
The Lancet Public Health, Vol 8, Iss 8, Pp e639-e650 (2023)
Summary: Background: South Korea has one of the longest operating universal health coverage (UHC) systems. A comprehensive analysis of long-term trajectories of morbidity and mortality in the South Korean population after the inception of UHC is need
Externí odkaz:
https://doaj.org/article/2dbfd441b4974f7e8ce86bd54709f2af
Publikováno v:
Clinical and Molecular Hepatology, Vol 28, Iss 2, Pp 164-173 (2022)
Hepatitis C virus (HCV) infection is the second most common cause of chronic liver disease in South Korea, with a prevalence ranging from 0.6% to 0.8%, and HCV infection incidence increases with age. The anti-HCV antibody test, which is cheaper than
Externí odkaz:
https://doaj.org/article/5ba4bd0ea2744d1587571cd15dc29a01
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Frequent exposure to antibiotic treatments may increase the risk of antibiotic resistance, which may threaten the effectiveness of future antibiotic treatments. Thus, it is important to identify the preventable risks in terms of a
Externí odkaz:
https://doaj.org/article/334f573f2e1a43e1880a290aae2ca477
Publikováno v:
International Clinical Psychopharmacology; Jul2024, Vol. 39 Issue 4, p240-249, 10p
Autor:
Seonyoung Park, Ah-Young Kim, Hyeonseok Cho, Deborah Baik, Hankil Lee, Sunghwa Cho, Hye-Young Kang
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Patients with relapsed or refractory peripheral T-cell lymphoma (R/R PTCL) treated with pralatrexate have previously shown superior overall survival (OS) compared to those who underwent conventional chemotherapy (CC, 15.4 vs. 4.07
Externí odkaz:
https://doaj.org/article/72199d28176c4a59aba4fbfd97fc9558
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244759 (2020)
IntroductionThe Korean National Health Insurance revised its reimbursement criteria to expand coverage for anti-osteoporotic drug treatments in 2011 (expanding diagnostic criteria and the coverage period for anti-osteoporotic therapy) and 2015 (inclu
Externí odkaz:
https://doaj.org/article/93ab6e421ff741ad9aaf6f44c1d68bb4